QIAGEN and Element Biosciences say they have entered a strategic partnership to offer next-generation sequencing (NGS) workflows for the Element AVITI™ benchtop system. For customers using the AVITI System, QIAGEN provides Sample to Insight NGS workflows with QIAseq panels and integrated bioinformatic solutions, including CLC LightSpeed and QCI Interpret software.

“The collaboration between QIAGEN and Element Biosciences delivers insights across various genomic applications to our customers worldwide,” said Nitin Sood, senior vice president, head of the life sciences business area at QIAGEN. “Researchers are increasingly searching for complete solutions and workflows from sample to insight, and we are committed to advancing the field together by providing innovative technology and applications that help researchers accelerate discovery.”

“Element and QIAGEN share the goals of offering flexible, cost-effective, and high-performance solutions to our customers,” added Yaron Hakak, PhD, senior vice president of corporate and business development at Element Biosciences. “Jointly promoting the combined workflow will help us serve an expanded customer base.”

QIAGEN’s QIAseq panels are designed for NGS library preparation. The QIAseq miRNA Library Kit, the QIAseq xHYB Actionable Exome Panel, and the QIAseq Targeted DNA Pro Panel have been validated on the AVITI sequencer, according to a QIAGEN official.

LightSpeed, a new module for QIAGEN CLC Genomics Workbench Premium, enables AVITI system users to perform whole genome sequencing (WGS) secondary analysis. QCI Interpret, a customizable software solution, facilitates NGS variant interpretation and reporting for oncology and hereditary applications, explained the QIAGEN spokesperson.

“There is a huge potential for NGS to deliver on the vision of precision medicine. One of the greatest barriers to ubiquitous adoption and use is the efficient downstream analysis and interpretation of processed samples,” said Jonathan Sheldon, PhD, senior vice president of QIAGEN Digital Insights. “We are pleased to partner with Element Biosciences to deliver joint solutions that enable customers to rapidly adopt, automate, and scale their NGS needs with higher cost efficiencies and faster turnaround times.”

Both partners will present data at the ongoing American Society of Human Genetics (ASHG) annual meeting in Washington, DC.

Previous articleGenomenon Delivers Fully Curated Clinical Exome at ASHG
Next articleAdvancing Understanding of Neurodegenerative Diseases Using Computational Methods